| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/13/2011 | WO2011004552A1 Water-soluble drug carrier and process for production thereof |
| 01/13/2011 | WO2011004395A1 Microemulsion formulation for biologicals |
| 01/13/2011 | WO2011004361A2 Long-acting coagulation factors and methods of producing same |
| 01/13/2011 | WO2011004260A2 Composition for the treatment of benign prostate hyperplasia |
| 01/13/2011 | WO2011004194A1 Method of treating age related disorders |
| 01/13/2011 | WO2011004148A1 Methods related to a mutation in complement factor h-related protein 5 in patients with glomerulonephritis |
| 01/13/2011 | WO2011004117A1 Method and pharmaceutical compositions for trans-buccal mucosa treatment of postprandial hyperglycaemia in type ii diabetes |
| 01/13/2011 | WO2011004054A1 Use of carbonic anhydrase ii for producing a drug |
| 01/13/2011 | WO2011004011A1 Variants of plasminogen and plasmin |
| 01/13/2011 | WO2011003823A1 Slow-acting insulin preparations |
| 01/13/2011 | WO2011003820A1 Heat- and vibration-stable insulin preparations |
| 01/13/2011 | WO2011003600A1 METHOD FOR THE PURIFICATION OF INTERFERON-β |
| 01/13/2011 | WO2011003138A1 Immunomodulating compositions comprising interleukin 13 inhibitors and uses therefor |
| 01/13/2011 | WO2010138839A9 Use of 2 anti-sparc antibodies to predict response to chemotherapy |
| 01/13/2011 | WO2010134686A3 Soluble myostatin pro-domain recombinant protein having myostatin inhibitory activity and use thereof |
| 01/13/2011 | WO2010133374A3 Therapeutic composition comprising microspheres |
| 01/13/2011 | WO2010129708A3 Methods and compositions related to the regulation of goblet cell differentiation, mucus production and mucus secretion |
| 01/13/2011 | WO2010122135A3 Use of mixed lineage like kinase polypeptides (mlkl polypeptides) in cancer therapy |
| 01/13/2011 | WO2010120431A3 Methods for the prevention and treatment of burn injuries and secondary complications |
| 01/13/2011 | WO2010105191A3 Antimicrobial compositions and methods of use therefore |
| 01/13/2011 | WO2010104341A3 Compositions for diagnosis of fungal infections |
| 01/13/2011 | WO2010103070A3 Bone morphogenetic protein 2 (bmp2) variants with reduced bmp antagonist sensitivity |
| 01/13/2011 | WO2010102277A3 Methods of diagnosing and treating prostate cancer characterized by ndrg1-erg fusion |
| 01/13/2011 | WO2010102253A3 Compositions and methods for modulation of cell migration |
| 01/13/2011 | WO2010102112A9 Treatment of drug-related side effect and tissue damage by targeting the cd24-hmgb1-siglec10 axis |
| 01/13/2011 | WO2010099510A3 Amino acid-based compounds, their methods of use, and methods of screening |
| 01/13/2011 | WO2010045586A3 Muc-1 cytoplasmic domain peptides as inhibitors of cancer |
| 01/13/2011 | US20110010785 Products and their use for the diagnosis, prevention and/or care of human and/or animal pathologies characterised by the anomalous deposition of b-amyloid and/or amyloid-like substance in human and/or animal organs and tissues, and screening method for determining the risk of such pathologies |
| 01/13/2011 | US20110009602 Human cd28 specific monoclonal antibodies for antigen-nonspecific activation of t-lymphocytes |
| 01/13/2011 | US20110009472 RNAi Probes Targeting Cancer-Related Proteins |
| 01/13/2011 | US20110009467 Methods to Increase or Decrease Bone Density |
| 01/13/2011 | US20110009392 Gamma secretase modulators |
| 01/13/2011 | US20110009346 Methods and compositions for increasing the anaerobic working capacity in tissues |
| 01/13/2011 | US20110009345 Food ingredient comprising functional peptide |
| 01/13/2011 | US20110009344 Control of radiation injury |
| 01/13/2011 | US20110009343 Modulators of amyloid aggregation |
| 01/13/2011 | US20110009342 Uses of pdcd5 polypeptide for tumor chemotherapy and organ protection |
| 01/13/2011 | US20110009341 N-Alkylated Cyclic Peptide Melanocortin Agonists |
| 01/13/2011 | US20110009340 Combination of an iron chelator and an immunosuppressant and use thereof |
| 01/13/2011 | US20110009339 Method of treating blurred vision and other conditions of the eye with cyclosporin compositions |
| 01/13/2011 | US20110009338 Controlled release formulations of octreotide |
| 01/13/2011 | US20110009337 Q3 sparc deletion mutant and uses thereof |
| 01/13/2011 | US20110009336 Treatment of Cancers with Immunostimulatory HIV TAT Derivative Polypeptides |
| 01/13/2011 | US20110009335 Anticancer Treatments |
| 01/13/2011 | US20110009334 System and method for inhibiting cellular proliferation with tachykinins |
| 01/13/2011 | US20110009333 Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration |
| 01/13/2011 | US20110009332 Therapeutic Treatment Of Wounds |
| 01/13/2011 | US20110009331 Protein kinase c peptides for use in withdrawal |
| 01/13/2011 | US20110009330 Medicament for treating parkinson's disease |
| 01/13/2011 | US20110009329 Method for treating neurodegenerative diseases |
| 01/13/2011 | US20110009328 Polypeptide Derivatives of Parathyroid Hormone (PTH) |
| 01/13/2011 | US20110009327 Bioactive nanocomposite material |
| 01/13/2011 | US20110009326 Methods or use of lamin b1 nuclear antigen, fragments and compositions thereof, for inhibiting or reducing a thrombotic event |
| 01/13/2011 | US20110009325 Crystalline forms of rapamycin analogs |
| 01/13/2011 | US20110009324 Stable Therapeutic Proteins |
| 01/13/2011 | US20110009323 Non-immunoglobulin antigen binding scaffolds for inhibiting angiogenesis and tumor growth |
| 01/13/2011 | US20110009322 Use of bradykinin and related b2r agonists to treat ocular hypertension and glaucoma |
| 01/13/2011 | US20110009321 Nasal calcitonin formulations containing chlorobutanol |
| 01/13/2011 | US20110009320 Glucagon-like peptide-2 analogs |
| 01/13/2011 | US20110009319 Cripto antagonism of activin and tgf-b signaling |
| 01/13/2011 | US20110009318 Transdermal Compositions and Methods for Treatment of Fibromyalgia and Chronic Fatigue Syndrome |
| 01/13/2011 | US20110009317 Conjugates of insulin-like growth factor-1 and poly(ethylene glycol) |
| 01/13/2011 | US20110009316 Proteolysis resistant active vegf |
| 01/13/2011 | US20110009315 Long-acting transient polymer conjugates of exendin |
| 01/13/2011 | US20110009314 Single-Chain Insulin Analogues and Pharmaceutical Formulations Thereof |
| 01/13/2011 | US20110009313 Polyethylene glycolated lactoferrin complex and method of producing the same |
| 01/13/2011 | US20110009312 Albumin Fusion Proteins |
| 01/13/2011 | US20110009311 Peptides and their utility in modulation of behavior of cells expressing alpha3 beta1 integrins |
| 01/13/2011 | US20110009310 Drug for treating states related to the inhibition of angiogenesis and/or endothelial cell proliferation |
| 01/13/2011 | US20110009308 Subtilase Variants Having Altered Immunogenicity |
| 01/13/2011 | US20110008913 Tumor suppressor gene |
| 01/13/2011 | US20110008890 Self-Assembly of Peptide-Amphiphile Nanofibers Under Physiological Conditions |
| 01/13/2011 | US20110008842 Novel chimeric tnf ligands |
| 01/13/2011 | US20110008762 Methods for Preserving Organs and Tissues |
| 01/13/2011 | US20110008476 Methods of Treating or Preventing Inflammatory Diseases of the Intestinal Tract |
| 01/13/2011 | US20110008464 Methods and compositions for treating thyroid-related medical conditions with reduced folates |
| 01/13/2011 | US20110008458 Process for removing growth factors from platelets |
| 01/13/2011 | US20110008455 Crosslinked Protein Nanocrystals, Crosslinked Protein Nanoaggregates and Method of Preparation Thereof |
| 01/13/2011 | US20110008450 Slow Release Compositions |
| 01/13/2011 | US20110008448 Diketopiperazine Salts for Drug Delivery and Related Methods |
| 01/13/2011 | US20110008447 Carrier comprising nanodiamond |
| 01/13/2011 | US20110008441 Thermoresponsive arginine-based hydrogels as biologic carriers |
| 01/13/2011 | US20110008440 Novel nanocompound materials with infrared, ultraviolet and visible electromagnetic radiation blocking properties and method for obtaining them |
| 01/13/2011 | US20110008438 Bone Repair Composition and a Method of Making the Same |
| 01/13/2011 | US20110008423 Pharmaceutical compositions comprising granules of purified microbial lipase and methods for preventing or treating digestive disorders |
| 01/13/2011 | US20110008422 System for delivery of protein in insoluble fibrillar or aggregate form |
| 01/13/2011 | US20110008418 Compositions and Methods for the Treatment of Cancer |
| 01/13/2011 | US20110008414 Method for synthesizing conformationally constrained peptides, peptidomimetics and the use thereof as synthetic vaccines |
| 01/13/2011 | US20110008402 Souluble b-n-acetylglucoseaminidase based antibiofilm compositions and uses thereof |
| 01/13/2011 | US20110008393 Nucleic acids and corresponding proteins entitled 58p1d12 useful in treatment and detection of cancer |
| 01/13/2011 | US20110008392 Vaccine targets and delivery systems for cryptosporidium |
| 01/13/2011 | US20110008377 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides |
| 01/13/2011 | US20110008375 Uses of Myostatin Antagonists |
| 01/13/2011 | US20110008371 Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of antecedent hematologic disorders |
| 01/13/2011 | US20110008363 Erythropoietin variants |
| 01/13/2011 | US20110008361 Treatment Method |
| 01/13/2011 | US20110008351 Anticomplement polypeptides of ixodes ricinus |
| 01/13/2011 | US20110008346 Biomarkers for cardiovascular disease |
| 01/13/2011 | US20110008343 Method Of Reducing Tissue Loss In Pancreatic Islet Cell Transplantation |
| 01/13/2011 | US20110008341 Polypeptides and methods for making the same |